Thomas J. Moore

机构：Johns Hopkins University · ORCID：0000-0003-0994-836X

发表论文 203 篇 · 总被引 25383 次 · h-index 50

代表论文

• Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016 (2018 · JAMA Internal Medicine · 被引 367)
• Reports of Pathological Gambling, Hypersexuality, and Compulsive Shopping Associated With Dopamine Receptor Agonist Drugs (2014 · JAMA Internal Medicine · 被引 323)
• Adult Utilization of Psychiatric Drugs and Differences by Sex, Age, and Race (2016 · JAMA Internal Medicine · 被引 209)
• Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional study (2020 · BMJ Open · 被引 121)
• Dabigatran, bleeding, and the regulators (2014 · BMJ · 被引 82)
• Development Times, Clinical Testing, Postmarket Follow-up, and Safety Risks for the New Drugs Approved by the US Food and Drug Administration (2013 · JAMA Internal Medicine · 被引 77)